CHEK2 and cancer: Chk2-deficient mice are viable and do not show increased cancer incidence (Donehower et al., 1992; Barlow et al., 1996; Hirao et al., 2002), constituting an interesting model to test the importance of this checkpoint kinase in mediating telomere dysfunction in vivo.